EUROPEAN JOURNAL OF CANCER PREVENTION-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2184280, encodeId=e033218428016, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：预测模型;预防医学;肿瘤科 经验分享：现在的网友真的是猪狗不如，随便的骗人说什么录用率90以上，结果我发表不到一个小时直接秒拒。随便骗人真的好吗？浪费我半天的查询，投稿，修改投稿版本，有些人我劝你做个人吧！European Journal of Cancer Prevention, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=044f4692216, createdName=906013302, createdTime=Sat Jan 27 13:49:38 CST 2024, time=2024-01-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2099462, encodeId=66d2209946284, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;癌症 经验分享：【HU】投稿全过程 19-9-2022 submitted 22-9-2022 with editor 25-9-2022 under review 08-10-2022 required reviews complete 10-10-2022 Decision in process 12-10-2022 acceptable for publication pending minor revision （3个审稿人提了4个小问题） 17-10-2022 resubmitted 21-10-2022 with editor 28-10-2022 Decision in process 02-11-2022 acceptable for publication pending minor revision （提了2个版权声明问题） 02-11-2022 resubmitted 03-11-2022 Decision in process 07-11-2022 Decision in process 08-11-2022 accepted 总结：本期刊比较偏向于肿瘤预防的临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Wed Nov 09 20:09:59 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094388, encodeId=43332094388b3, content=一周了，还是在with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=183b8350874, createdName=ms5000000629687219, createdTime=Tue Oct 18 11:12:34 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202197, encodeId=3551120219edb, content=审稿速度:6.0 经验分享：审稿6个月拒稿，期间催稿无回复，审稿意见是不够创新。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f31f5680453, createdName=ms5000000238051214, createdTime=Sun Mar 13 11:56:17 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090224, encodeId=f5ed1090224c3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090223, encodeId=cc0010902238a, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052498, encodeId=b2191052498b9, content=为什么看不到其他人的经验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44155568644, createdName=ms3000001717631578, createdTime=Sat Sep 18 09:57:00 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971064, encodeId=72bf9e1064fb, content=收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhNVzcfZpicVbeVAiay9TG7f7ibnJgLMWaT7uw3ubOicEnhHsa0noWvZ526f9ppdFyf8wOO2uEdhG3zQ/132, createdBy=33f85085346, createdName=1214022938_59139880, createdTime=Sat Jun 05 09:59:17 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585784, encodeId=d5f6585e843a, content=这个杂志要钱不？审稿费和版面费bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , beContent=bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5CoPhAIQLUBNXBI1pgx7FSTdXjIaAosVObrh0uMGIeJSUOapekqP02Vuqo72dM1NxPCXoPoE9aRG1CHK5N2Zpg/132, createdBy=f6e990747, createdName=kongfangzhuo, createdTime=Tue Mar 03 00:00:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842359, encodeId=88aa842359b6, content=审稿挺快的，一个月就有结果，而且还有外审专家的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Sun Apr 15 18:13:58 CST 2018, time=2018-04-15, status=1, ipAttribution=)]

2024-01-27 906013302 来自云南省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：预测模型;预防医学;肿瘤科
经验分享：现在的网友真的是猪狗不如，随便的骗人说什么录用率90以上，结果我发表不到一个小时直接秒拒。随便骗人真的好吗？浪费我半天的查询，投稿，修改投稿版本，有些人我劝你做个人吧！European Journal of Cancer Prevention

15 0

[GetPortalCommentsPageByObjectIdResponse(id=2184280, encodeId=e033218428016, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：预测模型;预防医学;肿瘤科 经验分享：现在的网友真的是猪狗不如，随便的骗人说什么录用率90以上，结果我发表不到一个小时直接秒拒。随便骗人真的好吗？浪费我半天的查询，投稿，修改投稿版本，有些人我劝你做个人吧！European Journal of Cancer Prevention, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=044f4692216, createdName=906013302, createdTime=Sat Jan 27 13:49:38 CST 2024, time=2024-01-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2099462, encodeId=66d2209946284, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;癌症 经验分享：【HU】投稿全过程 19-9-2022 submitted 22-9-2022 with editor 25-9-2022 under review 08-10-2022 required reviews complete 10-10-2022 Decision in process 12-10-2022 acceptable for publication pending minor revision （3个审稿人提了4个小问题） 17-10-2022 resubmitted 21-10-2022 with editor 28-10-2022 Decision in process 02-11-2022 acceptable for publication pending minor revision （提了2个版权声明问题） 02-11-2022 resubmitted 03-11-2022 Decision in process 07-11-2022 Decision in process 08-11-2022 accepted 总结：本期刊比较偏向于肿瘤预防的临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Wed Nov 09 20:09:59 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094388, encodeId=43332094388b3, content=一周了，还是在with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=183b8350874, createdName=ms5000000629687219, createdTime=Tue Oct 18 11:12:34 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202197, encodeId=3551120219edb, content=审稿速度:6.0 经验分享：审稿6个月拒稿，期间催稿无回复，审稿意见是不够创新。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f31f5680453, createdName=ms5000000238051214, createdTime=Sun Mar 13 11:56:17 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090224, encodeId=f5ed1090224c3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090223, encodeId=cc0010902238a, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052498, encodeId=b2191052498b9, content=为什么看不到其他人的经验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44155568644, createdName=ms3000001717631578, createdTime=Sat Sep 18 09:57:00 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971064, encodeId=72bf9e1064fb, content=收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhNVzcfZpicVbeVAiay9TG7f7ibnJgLMWaT7uw3ubOicEnhHsa0noWvZ526f9ppdFyf8wOO2uEdhG3zQ/132, createdBy=33f85085346, createdName=1214022938_59139880, createdTime=Sat Jun 05 09:59:17 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585784, encodeId=d5f6585e843a, content=这个杂志要钱不？审稿费和版面费bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , beContent=bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5CoPhAIQLUBNXBI1pgx7FSTdXjIaAosVObrh0uMGIeJSUOapekqP02Vuqo72dM1NxPCXoPoE9aRG1CHK5N2Zpg/132, createdBy=f6e990747, createdName=kongfangzhuo, createdTime=Tue Mar 03 00:00:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842359, encodeId=88aa842359b6, content=审稿挺快的，一个月就有结果，而且还有外审专家的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Sun Apr 15 18:13:58 CST 2018, time=2018-04-15, status=1, ipAttribution=)]

2022-11-09 小白先生

审稿速度:1.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤学;癌症
经验分享：【HU】投稿全过程 19-9-2022 submitted 22-9-2022 with editor 25-9-2022 under review 08-10-2022 required reviews complete 10-10-2022 Decision in process 12-10-2022 acceptable for publication pending minor revision （3个审稿人提了4个小问题） 17-10-2022 resubmitted 21-10-2022 with editor 28-10-2022 Decision in process 02-11-2022 acceptable for publication pending minor revision （提了2个版权声明问题） 02-11-2022 resubmitted 03-11-2022 Decision in process 07-11-2022 Decision in process 08-11-2022 accepted 总结：本期刊比较偏向于肿瘤预防的临床研究

43 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184280, encodeId=e033218428016, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：预测模型;预防医学;肿瘤科 经验分享：现在的网友真的是猪狗不如，随便的骗人说什么录用率90以上，结果我发表不到一个小时直接秒拒。随便骗人真的好吗？浪费我半天的查询，投稿，修改投稿版本，有些人我劝你做个人吧！European Journal of Cancer Prevention, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=044f4692216, createdName=906013302, createdTime=Sat Jan 27 13:49:38 CST 2024, time=2024-01-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2099462, encodeId=66d2209946284, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;癌症 经验分享：【HU】投稿全过程 19-9-2022 submitted 22-9-2022 with editor 25-9-2022 under review 08-10-2022 required reviews complete 10-10-2022 Decision in process 12-10-2022 acceptable for publication pending minor revision （3个审稿人提了4个小问题） 17-10-2022 resubmitted 21-10-2022 with editor 28-10-2022 Decision in process 02-11-2022 acceptable for publication pending minor revision （提了2个版权声明问题） 02-11-2022 resubmitted 03-11-2022 Decision in process 07-11-2022 Decision in process 08-11-2022 accepted 总结：本期刊比较偏向于肿瘤预防的临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Wed Nov 09 20:09:59 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094388, encodeId=43332094388b3, content=一周了，还是在with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=183b8350874, createdName=ms5000000629687219, createdTime=Tue Oct 18 11:12:34 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202197, encodeId=3551120219edb, content=审稿速度:6.0 经验分享：审稿6个月拒稿，期间催稿无回复，审稿意见是不够创新。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f31f5680453, createdName=ms5000000238051214, createdTime=Sun Mar 13 11:56:17 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090224, encodeId=f5ed1090224c3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090223, encodeId=cc0010902238a, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052498, encodeId=b2191052498b9, content=为什么看不到其他人的经验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44155568644, createdName=ms3000001717631578, createdTime=Sat Sep 18 09:57:00 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971064, encodeId=72bf9e1064fb, content=收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhNVzcfZpicVbeVAiay9TG7f7ibnJgLMWaT7uw3ubOicEnhHsa0noWvZ526f9ppdFyf8wOO2uEdhG3zQ/132, createdBy=33f85085346, createdName=1214022938_59139880, createdTime=Sat Jun 05 09:59:17 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585784, encodeId=d5f6585e843a, content=这个杂志要钱不？审稿费和版面费bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , beContent=bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5CoPhAIQLUBNXBI1pgx7FSTdXjIaAosVObrh0uMGIeJSUOapekqP02Vuqo72dM1NxPCXoPoE9aRG1CHK5N2Zpg/132, createdBy=f6e990747, createdName=kongfangzhuo, createdTime=Tue Mar 03 00:00:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842359, encodeId=88aa842359b6, content=审稿挺快的，一个月就有结果，而且还有外审专家的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Sun Apr 15 18:13:58 CST 2018, time=2018-04-15, status=1, ipAttribution=)]

2022-10-18 ms5000000629687219

一周了，还是在with editor正常吗？

54 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184280, encodeId=e033218428016, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：预测模型;预防医学;肿瘤科 经验分享：现在的网友真的是猪狗不如，随便的骗人说什么录用率90以上，结果我发表不到一个小时直接秒拒。随便骗人真的好吗？浪费我半天的查询，投稿，修改投稿版本，有些人我劝你做个人吧！European Journal of Cancer Prevention, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=044f4692216, createdName=906013302, createdTime=Sat Jan 27 13:49:38 CST 2024, time=2024-01-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2099462, encodeId=66d2209946284, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;癌症 经验分享：【HU】投稿全过程 19-9-2022 submitted 22-9-2022 with editor 25-9-2022 under review 08-10-2022 required reviews complete 10-10-2022 Decision in process 12-10-2022 acceptable for publication pending minor revision （3个审稿人提了4个小问题） 17-10-2022 resubmitted 21-10-2022 with editor 28-10-2022 Decision in process 02-11-2022 acceptable for publication pending minor revision （提了2个版权声明问题） 02-11-2022 resubmitted 03-11-2022 Decision in process 07-11-2022 Decision in process 08-11-2022 accepted 总结：本期刊比较偏向于肿瘤预防的临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Wed Nov 09 20:09:59 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094388, encodeId=43332094388b3, content=一周了，还是在with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=183b8350874, createdName=ms5000000629687219, createdTime=Tue Oct 18 11:12:34 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202197, encodeId=3551120219edb, content=审稿速度:6.0 经验分享：审稿6个月拒稿，期间催稿无回复，审稿意见是不够创新。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f31f5680453, createdName=ms5000000238051214, createdTime=Sun Mar 13 11:56:17 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090224, encodeId=f5ed1090224c3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090223, encodeId=cc0010902238a, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052498, encodeId=b2191052498b9, content=为什么看不到其他人的经验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44155568644, createdName=ms3000001717631578, createdTime=Sat Sep 18 09:57:00 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971064, encodeId=72bf9e1064fb, content=收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhNVzcfZpicVbeVAiay9TG7f7ibnJgLMWaT7uw3ubOicEnhHsa0noWvZ526f9ppdFyf8wOO2uEdhG3zQ/132, createdBy=33f85085346, createdName=1214022938_59139880, createdTime=Sat Jun 05 09:59:17 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585784, encodeId=d5f6585e843a, content=这个杂志要钱不？审稿费和版面费bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , beContent=bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5CoPhAIQLUBNXBI1pgx7FSTdXjIaAosVObrh0uMGIeJSUOapekqP02Vuqo72dM1NxPCXoPoE9aRG1CHK5N2Zpg/132, createdBy=f6e990747, createdName=kongfangzhuo, createdTime=Tue Mar 03 00:00:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842359, encodeId=88aa842359b6, content=审稿挺快的，一个月就有结果，而且还有外审专家的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Sun Apr 15 18:13:58 CST 2018, time=2018-04-15, status=1, ipAttribution=)]

2022-03-13 ms5000000238051214

审稿速度:6.0
经验分享：审稿6个月拒稿，期间催稿无回复，审稿意见是不够创新。

219 0

[GetPortalCommentsPageByObjectIdResponse(id=2184280, encodeId=e033218428016, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：预测模型;预防医学;肿瘤科 经验分享：现在的网友真的是猪狗不如，随便的骗人说什么录用率90以上，结果我发表不到一个小时直接秒拒。随便骗人真的好吗？浪费我半天的查询，投稿，修改投稿版本，有些人我劝你做个人吧！European Journal of Cancer Prevention, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=044f4692216, createdName=906013302, createdTime=Sat Jan 27 13:49:38 CST 2024, time=2024-01-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2099462, encodeId=66d2209946284, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;癌症 经验分享：【HU】投稿全过程 19-9-2022 submitted 22-9-2022 with editor 25-9-2022 under review 08-10-2022 required reviews complete 10-10-2022 Decision in process 12-10-2022 acceptable for publication pending minor revision （3个审稿人提了4个小问题） 17-10-2022 resubmitted 21-10-2022 with editor 28-10-2022 Decision in process 02-11-2022 acceptable for publication pending minor revision （提了2个版权声明问题） 02-11-2022 resubmitted 03-11-2022 Decision in process 07-11-2022 Decision in process 08-11-2022 accepted 总结：本期刊比较偏向于肿瘤预防的临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Wed Nov 09 20:09:59 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094388, encodeId=43332094388b3, content=一周了，还是在with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=183b8350874, createdName=ms5000000629687219, createdTime=Tue Oct 18 11:12:34 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202197, encodeId=3551120219edb, content=审稿速度:6.0 经验分享：审稿6个月拒稿，期间催稿无回复，审稿意见是不够创新。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f31f5680453, createdName=ms5000000238051214, createdTime=Sun Mar 13 11:56:17 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090224, encodeId=f5ed1090224c3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090223, encodeId=cc0010902238a, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052498, encodeId=b2191052498b9, content=为什么看不到其他人的经验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44155568644, createdName=ms3000001717631578, createdTime=Sat Sep 18 09:57:00 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971064, encodeId=72bf9e1064fb, content=收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhNVzcfZpicVbeVAiay9TG7f7ibnJgLMWaT7uw3ubOicEnhHsa0noWvZ526f9ppdFyf8wOO2uEdhG3zQ/132, createdBy=33f85085346, createdName=1214022938_59139880, createdTime=Sat Jun 05 09:59:17 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585784, encodeId=d5f6585e843a, content=这个杂志要钱不？审稿费和版面费bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , beContent=bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5CoPhAIQLUBNXBI1pgx7FSTdXjIaAosVObrh0uMGIeJSUOapekqP02Vuqo72dM1NxPCXoPoE9aRG1CHK5N2Zpg/132, createdBy=f6e990747, createdName=kongfangzhuo, createdTime=Tue Mar 03 00:00:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842359, encodeId=88aa842359b6, content=审稿挺快的，一个月就有结果，而且还有外审专家的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Sun Apr 15 18:13:58 CST 2018, time=2018-04-15, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

什么是推荐reviewer/专家/同行？

274 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184280, encodeId=e033218428016, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：预测模型;预防医学;肿瘤科 经验分享：现在的网友真的是猪狗不如，随便的骗人说什么录用率90以上，结果我发表不到一个小时直接秒拒。随便骗人真的好吗？浪费我半天的查询，投稿，修改投稿版本，有些人我劝你做个人吧！European Journal of Cancer Prevention, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=044f4692216, createdName=906013302, createdTime=Sat Jan 27 13:49:38 CST 2024, time=2024-01-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2099462, encodeId=66d2209946284, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;癌症 经验分享：【HU】投稿全过程 19-9-2022 submitted 22-9-2022 with editor 25-9-2022 under review 08-10-2022 required reviews complete 10-10-2022 Decision in process 12-10-2022 acceptable for publication pending minor revision （3个审稿人提了4个小问题） 17-10-2022 resubmitted 21-10-2022 with editor 28-10-2022 Decision in process 02-11-2022 acceptable for publication pending minor revision （提了2个版权声明问题） 02-11-2022 resubmitted 03-11-2022 Decision in process 07-11-2022 Decision in process 08-11-2022 accepted 总结：本期刊比较偏向于肿瘤预防的临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Wed Nov 09 20:09:59 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094388, encodeId=43332094388b3, content=一周了，还是在with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=183b8350874, createdName=ms5000000629687219, createdTime=Tue Oct 18 11:12:34 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202197, encodeId=3551120219edb, content=审稿速度:6.0 经验分享：审稿6个月拒稿，期间催稿无回复，审稿意见是不够创新。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f31f5680453, createdName=ms5000000238051214, createdTime=Sun Mar 13 11:56:17 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090224, encodeId=f5ed1090224c3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090223, encodeId=cc0010902238a, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052498, encodeId=b2191052498b9, content=为什么看不到其他人的经验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44155568644, createdName=ms3000001717631578, createdTime=Sat Sep 18 09:57:00 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971064, encodeId=72bf9e1064fb, content=收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhNVzcfZpicVbeVAiay9TG7f7ibnJgLMWaT7uw3ubOicEnhHsa0noWvZ526f9ppdFyf8wOO2uEdhG3zQ/132, createdBy=33f85085346, createdName=1214022938_59139880, createdTime=Sat Jun 05 09:59:17 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585784, encodeId=d5f6585e843a, content=这个杂志要钱不？审稿费和版面费bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , beContent=bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5CoPhAIQLUBNXBI1pgx7FSTdXjIaAosVObrh0uMGIeJSUOapekqP02Vuqo72dM1NxPCXoPoE9aRG1CHK5N2Zpg/132, createdBy=f6e990747, createdName=kongfangzhuo, createdTime=Tue Mar 03 00:00:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842359, encodeId=88aa842359b6, content=审稿挺快的，一个月就有结果，而且还有外审专家的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Sun Apr 15 18:13:58 CST 2018, time=2018-04-15, status=1, ipAttribution=)]

2021-12-27 MS54455111222

上传文章时应该上传word还是pdf？

243 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2184280, encodeId=e033218428016, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：预测模型;预防医学;肿瘤科 经验分享：现在的网友真的是猪狗不如，随便的骗人说什么录用率90以上，结果我发表不到一个小时直接秒拒。随便骗人真的好吗？浪费我半天的查询，投稿，修改投稿版本，有些人我劝你做个人吧！European Journal of Cancer Prevention, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=044f4692216, createdName=906013302, createdTime=Sat Jan 27 13:49:38 CST 2024, time=2024-01-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2099462, encodeId=66d2209946284, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;癌症 经验分享：【HU】投稿全过程 19-9-2022 submitted 22-9-2022 with editor 25-9-2022 under review 08-10-2022 required reviews complete 10-10-2022 Decision in process 12-10-2022 acceptable for publication pending minor revision （3个审稿人提了4个小问题） 17-10-2022 resubmitted 21-10-2022 with editor 28-10-2022 Decision in process 02-11-2022 acceptable for publication pending minor revision （提了2个版权声明问题） 02-11-2022 resubmitted 03-11-2022 Decision in process 07-11-2022 Decision in process 08-11-2022 accepted 总结：本期刊比较偏向于肿瘤预防的临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Wed Nov 09 20:09:59 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094388, encodeId=43332094388b3, content=一周了，还是在with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=183b8350874, createdName=ms5000000629687219, createdTime=Tue Oct 18 11:12:34 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202197, encodeId=3551120219edb, content=审稿速度:6.0 经验分享：审稿6个月拒稿，期间催稿无回复，审稿意见是不够创新。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f31f5680453, createdName=ms5000000238051214, createdTime=Sun Mar 13 11:56:17 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090224, encodeId=f5ed1090224c3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090223, encodeId=cc0010902238a, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052498, encodeId=b2191052498b9, content=为什么看不到其他人的经验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44155568644, createdName=ms3000001717631578, createdTime=Sat Sep 18 09:57:00 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971064, encodeId=72bf9e1064fb, content=收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhNVzcfZpicVbeVAiay9TG7f7ibnJgLMWaT7uw3ubOicEnhHsa0noWvZ526f9ppdFyf8wOO2uEdhG3zQ/132, createdBy=33f85085346, createdName=1214022938_59139880, createdTime=Sat Jun 05 09:59:17 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585784, encodeId=d5f6585e843a, content=这个杂志要钱不？审稿费和版面费bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , beContent=bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5CoPhAIQLUBNXBI1pgx7FSTdXjIaAosVObrh0uMGIeJSUOapekqP02Vuqo72dM1NxPCXoPoE9aRG1CHK5N2Zpg/132, createdBy=f6e990747, createdName=kongfangzhuo, createdTime=Tue Mar 03 00:00:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842359, encodeId=88aa842359b6, content=审稿挺快的，一个月就有结果，而且还有外审专家的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Sun Apr 15 18:13:58 CST 2018, time=2018-04-15, status=1, ipAttribution=)]

2021-09-18 ms3000001717631578

为什么看不到其他人的经验呢

276 0

[GetPortalCommentsPageByObjectIdResponse(id=2184280, encodeId=e033218428016, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：预测模型;预防医学;肿瘤科 经验分享：现在的网友真的是猪狗不如，随便的骗人说什么录用率90以上，结果我发表不到一个小时直接秒拒。随便骗人真的好吗？浪费我半天的查询，投稿，修改投稿版本，有些人我劝你做个人吧！European Journal of Cancer Prevention, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=044f4692216, createdName=906013302, createdTime=Sat Jan 27 13:49:38 CST 2024, time=2024-01-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2099462, encodeId=66d2209946284, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;癌症 经验分享：【HU】投稿全过程 19-9-2022 submitted 22-9-2022 with editor 25-9-2022 under review 08-10-2022 required reviews complete 10-10-2022 Decision in process 12-10-2022 acceptable for publication pending minor revision （3个审稿人提了4个小问题） 17-10-2022 resubmitted 21-10-2022 with editor 28-10-2022 Decision in process 02-11-2022 acceptable for publication pending minor revision （提了2个版权声明问题） 02-11-2022 resubmitted 03-11-2022 Decision in process 07-11-2022 Decision in process 08-11-2022 accepted 总结：本期刊比较偏向于肿瘤预防的临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Wed Nov 09 20:09:59 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094388, encodeId=43332094388b3, content=一周了，还是在with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=183b8350874, createdName=ms5000000629687219, createdTime=Tue Oct 18 11:12:34 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202197, encodeId=3551120219edb, content=审稿速度:6.0 经验分享：审稿6个月拒稿，期间催稿无回复，审稿意见是不够创新。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f31f5680453, createdName=ms5000000238051214, createdTime=Sun Mar 13 11:56:17 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090224, encodeId=f5ed1090224c3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090223, encodeId=cc0010902238a, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052498, encodeId=b2191052498b9, content=为什么看不到其他人的经验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44155568644, createdName=ms3000001717631578, createdTime=Sat Sep 18 09:57:00 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971064, encodeId=72bf9e1064fb, content=收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhNVzcfZpicVbeVAiay9TG7f7ibnJgLMWaT7uw3ubOicEnhHsa0noWvZ526f9ppdFyf8wOO2uEdhG3zQ/132, createdBy=33f85085346, createdName=1214022938_59139880, createdTime=Sat Jun 05 09:59:17 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585784, encodeId=d5f6585e843a, content=这个杂志要钱不？审稿费和版面费bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , beContent=bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5CoPhAIQLUBNXBI1pgx7FSTdXjIaAosVObrh0uMGIeJSUOapekqP02Vuqo72dM1NxPCXoPoE9aRG1CHK5N2Zpg/132, createdBy=f6e990747, createdName=kongfangzhuo, createdTime=Tue Mar 03 00:00:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842359, encodeId=88aa842359b6, content=审稿挺快的，一个月就有结果，而且还有外审专家的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Sun Apr 15 18:13:58 CST 2018, time=2018-04-15, status=1, ipAttribution=)]

2021-06-05 1214022938_59139880

收费吗

270 0

[GetPortalCommentsPageByObjectIdResponse(id=2184280, encodeId=e033218428016, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：预测模型;预防医学;肿瘤科 经验分享：现在的网友真的是猪狗不如，随便的骗人说什么录用率90以上，结果我发表不到一个小时直接秒拒。随便骗人真的好吗？浪费我半天的查询，投稿，修改投稿版本，有些人我劝你做个人吧！European Journal of Cancer Prevention, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=044f4692216, createdName=906013302, createdTime=Sat Jan 27 13:49:38 CST 2024, time=2024-01-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2099462, encodeId=66d2209946284, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;癌症 经验分享：【HU】投稿全过程 19-9-2022 submitted 22-9-2022 with editor 25-9-2022 under review 08-10-2022 required reviews complete 10-10-2022 Decision in process 12-10-2022 acceptable for publication pending minor revision （3个审稿人提了4个小问题） 17-10-2022 resubmitted 21-10-2022 with editor 28-10-2022 Decision in process 02-11-2022 acceptable for publication pending minor revision （提了2个版权声明问题） 02-11-2022 resubmitted 03-11-2022 Decision in process 07-11-2022 Decision in process 08-11-2022 accepted 总结：本期刊比较偏向于肿瘤预防的临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Wed Nov 09 20:09:59 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094388, encodeId=43332094388b3, content=一周了，还是在with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=183b8350874, createdName=ms5000000629687219, createdTime=Tue Oct 18 11:12:34 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202197, encodeId=3551120219edb, content=审稿速度:6.0 经验分享：审稿6个月拒稿，期间催稿无回复，审稿意见是不够创新。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f31f5680453, createdName=ms5000000238051214, createdTime=Sun Mar 13 11:56:17 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090224, encodeId=f5ed1090224c3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090223, encodeId=cc0010902238a, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052498, encodeId=b2191052498b9, content=为什么看不到其他人的经验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44155568644, createdName=ms3000001717631578, createdTime=Sat Sep 18 09:57:00 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971064, encodeId=72bf9e1064fb, content=收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhNVzcfZpicVbeVAiay9TG7f7ibnJgLMWaT7uw3ubOicEnhHsa0noWvZ526f9ppdFyf8wOO2uEdhG3zQ/132, createdBy=33f85085346, createdName=1214022938_59139880, createdTime=Sat Jun 05 09:59:17 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585784, encodeId=d5f6585e843a, content=这个杂志要钱不？审稿费和版面费bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , beContent=bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5CoPhAIQLUBNXBI1pgx7FSTdXjIaAosVObrh0uMGIeJSUOapekqP02Vuqo72dM1NxPCXoPoE9aRG1CHK5N2Zpg/132, createdBy=f6e990747, createdName=kongfangzhuo, createdTime=Tue Mar 03 00:00:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842359, encodeId=88aa842359b6, content=审稿挺快的，一个月就有结果，而且还有外审专家的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Sun Apr 15 18:13:58 CST 2018, time=2018-04-15, status=1, ipAttribution=)]

2020-03-03 kongfangzhuo

这个杂志要钱不？审稿费和版面费bingbing198274 2016-02-11 15:28:00 发表:
Oct 23 2014 05:54:30:915AM
Dear Mrs
I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below.

额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！

bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM
Dear Mrs
I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below.

额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！

326 0

[GetPortalCommentsPageByObjectIdResponse(id=2184280, encodeId=e033218428016, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：预测模型;预防医学;肿瘤科 经验分享：现在的网友真的是猪狗不如，随便的骗人说什么录用率90以上，结果我发表不到一个小时直接秒拒。随便骗人真的好吗？浪费我半天的查询，投稿，修改投稿版本，有些人我劝你做个人吧！European Journal of Cancer Prevention, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=044f4692216, createdName=906013302, createdTime=Sat Jan 27 13:49:38 CST 2024, time=2024-01-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2099462, encodeId=66d2209946284, content=审稿速度:1.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤学;癌症 经验分享：【HU】投稿全过程 19-9-2022 submitted 22-9-2022 with editor 25-9-2022 under review 08-10-2022 required reviews complete 10-10-2022 Decision in process 12-10-2022 acceptable for publication pending minor revision （3个审稿人提了4个小问题） 17-10-2022 resubmitted 21-10-2022 with editor 28-10-2022 Decision in process 02-11-2022 acceptable for publication pending minor revision （提了2个版权声明问题） 02-11-2022 resubmitted 03-11-2022 Decision in process 07-11-2022 Decision in process 08-11-2022 accepted 总结：本期刊比较偏向于肿瘤预防的临床研究, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/80bdeec0f3f34445aac0344bb5d0ca22/eafe07d5604f4c0a85d42d0f35be2184.jpg, createdBy=2ae15443834, createdName=小白先生, createdTime=Wed Nov 09 20:09:59 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2094388, encodeId=43332094388b3, content=一周了，还是在with editor正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=183b8350874, createdName=ms5000000629687219, createdTime=Tue Oct 18 11:12:34 CST 2022, time=2022-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202197, encodeId=3551120219edb, content=审稿速度:6.0 经验分享：审稿6个月拒稿，期间催稿无回复，审稿意见是不够创新。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=219, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f31f5680453, createdName=ms5000000238051214, createdTime=Sun Mar 13 11:56:17 CST 2022, time=2022-03-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090224, encodeId=f5ed1090224c3, content=什么是推荐reviewer/专家/同行？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=274, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090223, encodeId=cc0010902238a, content=上传文章时应该上传word还是pdf？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=243, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1052498, encodeId=b2191052498b9, content=为什么看不到其他人的经验呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=276, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=44155568644, createdName=ms3000001717631578, createdTime=Sat Sep 18 09:57:00 CST 2021, time=2021-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971064, encodeId=72bf9e1064fb, content=收费吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=270, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKhNVzcfZpicVbeVAiay9TG7f7ibnJgLMWaT7uw3ubOicEnhHsa0noWvZ526f9ppdFyf8wOO2uEdhG3zQ/132, createdBy=33f85085346, createdName=1214022938_59139880, createdTime=Sat Jun 05 09:59:17 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=585784, encodeId=d5f6585e843a, content=这个杂志要钱不？审稿费和版面费bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , beContent=bingbing198274 2016-02-11 15:28:00 发表: Oct 23 2014 05:54:30:915AM Dear Mrs I am pleased to inform you that your paper has been found acceptable for publication pending appropriate revision. Please find the comments of the reviewers listed below. 额了个神额，2014.12.23邮件告诉我接收了，可是邮箱里垃圾邮件太多我没看到邮件.....。这回悲剧了！！！泪奔中！ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=326, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5CoPhAIQLUBNXBI1pgx7FSTdXjIaAosVObrh0uMGIeJSUOapekqP02Vuqo72dM1NxPCXoPoE9aRG1CHK5N2Zpg/132, createdBy=f6e990747, createdName=kongfangzhuo, createdTime=Tue Mar 03 00:00:00 CST 2020, time=2020-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=842359, encodeId=88aa842359b6, content=审稿挺快的，一个月就有结果，而且还有外审专家的意见。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=315, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69885414022, createdName=ms9526231670310936, createdTime=Sun Apr 15 18:13:58 CST 2018, time=2018-04-15, status=1, ipAttribution=)]

2018-04-15 ms9526231670310936

审稿挺快的，一个月就有结果，而且还有外审专家的意见。

315 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务